Barnea, I.; Luria, L.; Girsault, A.; Dabah, O.; Dudaie, M.; Mirsky, S.K.; Merkel, D.; Shaked, N.T.
Analyzing Blood Cells of High-Risk Myelodysplastic Syndrome Patients Using Interferometric Phase Microscopy and Fluorescent Flow Cytometry. Bioengineering 2024, 11, 256.
https://doi.org/10.3390/bioengineering11030256
AMA Style
Barnea I, Luria L, Girsault A, Dabah O, Dudaie M, Mirsky SK, Merkel D, Shaked NT.
Analyzing Blood Cells of High-Risk Myelodysplastic Syndrome Patients Using Interferometric Phase Microscopy and Fluorescent Flow Cytometry. Bioengineering. 2024; 11(3):256.
https://doi.org/10.3390/bioengineering11030256
Chicago/Turabian Style
Barnea, Itay, Lior Luria, Arik Girsault, Ofira Dabah, Matan Dudaie, Simcha K. Mirsky, Drorit Merkel, and Natan T. Shaked.
2024. "Analyzing Blood Cells of High-Risk Myelodysplastic Syndrome Patients Using Interferometric Phase Microscopy and Fluorescent Flow Cytometry" Bioengineering 11, no. 3: 256.
https://doi.org/10.3390/bioengineering11030256
APA Style
Barnea, I., Luria, L., Girsault, A., Dabah, O., Dudaie, M., Mirsky, S. K., Merkel, D., & Shaked, N. T.
(2024). Analyzing Blood Cells of High-Risk Myelodysplastic Syndrome Patients Using Interferometric Phase Microscopy and Fluorescent Flow Cytometry. Bioengineering, 11(3), 256.
https://doi.org/10.3390/bioengineering11030256
